Can aspirin increase or decrease vascepa's cardiovascular protection?

Can aspirin change Vascepa’s cardiovascular protection?

The provided sources don’t state whether aspirin increases or decreases the cardiovascular protection seen with Vascepa (icosapent ethyl). Vascepa’s cardiovascular benefit is tied to its effects as an EPA-based omega-3 therapy, but no specific interaction with aspirin’s impact on that benefit is given here [1].

What we know about combining aspirin with omega-3s like Vascepa

The sources provided don’t include results that directly compare cardiovascular outcomes for people taking Vascepa with vs. without aspirin. So you can’t determine from this information whether aspirin modifies Vascepa’s risk reduction [1].

Does aspirin change the expected effects of EPA (Vascepa)?

No mechanism or clinical evidence in the provided information connects aspirin to increased or reduced EPA (Vascepa) cardiovascular effectiveness [1].

Practical takeaway for someone asking this clinically

From the information available here, there’s no basis to say aspirin will increase or decrease Vascepa’s cardiovascular protection [1]. If you’re making medication decisions, it’s best to rely on your clinician’s guidance for your specific cardiovascular risk profile and any bleeding risk factors.

Sources:
[1] https://www.heart.org/en/health-topics/consumer-healthcare/prescription-medicines/vascepa-icosapent-ethyl